GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Gemina Laboratories Ltd (OTCPK:GLABF) » Definitions » Gross-Profit-to-Asset %

GLABF (Gemina Laboratories) Gross-Profit-to-Asset % : 0.00% (As of Oct. 2024)


View and export this data going back to 2022. Start your Free Trial

What is Gemina Laboratories Gross-Profit-to-Asset %?

Gross-Profit-to-Asset % is calculated as Gross Profit divided by its average Total Assets over a certain period of time. Gemina Laboratories's annualized Gross Profit for the quarter that ended in Oct. 2024 was $0.00 Mil. Gemina Laboratories's average Total Assets over the quarter that ended in Oct. 2024 was $1.10 Mil. Therefore, Gemina Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2024 was 0.00%.


Gemina Laboratories Gross-Profit-to-Asset % Historical Data

The historical data trend for Gemina Laboratories's Gross-Profit-to-Asset % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Gemina Laboratories Gross-Profit-to-Asset % Chart

Gemina Laboratories Annual Data
Trend Jan21 Jan22 Jan23 Jan24
Gross-Profit-to-Asset %
- - - -

Gemina Laboratories Quarterly Data
Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24
Gross-Profit-to-Asset % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Gemina Laboratories's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Gemina Laboratories's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Gemina Laboratories's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Gemina Laboratories's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Gemina Laboratories's Gross-Profit-to-Asset % falls into.


;
;

Gemina Laboratories Gross-Profit-to-Asset % Calculation

Gemina Laboratories's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jan. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (A: Jan. 2024 )/( (Total Assets (A: Jan. 2023 )+Total Assets (A: Jan. 2024 ))/ count )
=0/( (1.397+1.085)/ 2 )
=0/1.241
=0.00 %

Gemina Laboratories's annualized Gross-Profit-to-Asset % for the quarter that ended in Oct. 2024 is calculated as:

Gross-Profit-to-Asset %=Gross Profit (Q: Oct. 2024 )/( (Total Assets (Q: Jul. 2024 )+Total Assets (Q: Oct. 2024 ))/ count )
=0/( (1.092+1.112)/ 2 )
=0/1.102
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Oct. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.


Gemina Laboratories Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Gemina Laboratories's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.


Gemina Laboratories Business Description

Traded in Other Exchanges
Address
3800 Gilmore Mall, Suite 302, Burnaby, BC, CAN, V5G 4R8
Gemina Laboratories Ltd is a biotechnology company that operates in the In Vitro Diagnostics (IVD) and human wellness monitoring market under the name Gemina Labs. The company endeavors to develop novel surface functionalization chemistries for the detection of pathogens and biomarkers.